Texas Oncology - Central/South Texas ( Site 8003)

Austin, Texas 78731

2 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer Metastatic, Prostatic Neoplasms

Studies at this site

• Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) — Recruiting now
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) — Recruiting now